Echoing earlier results from both INCA global and NCUK UK surveys, this study highlights the considerable burden experienced by patients living with Neuroendocrine Cancer (in France) and identifies the need for improved awareness of this condition among HCPs to facilitate a faster diagnosis and referral for treatment. Although many patients have access to ‘NET specialist centers’ and participation in clinical trials, improved access for all French patients to innovation and information is of key importance.

You can read the full article here.